Search Orphan Drug Designations and Approvals
-
| Generic Name: | replication-deficient recombinant serotype 2 adeno-associated viral vector containing hAQP1 cDNA |
|---|---|
| Date Designated: | 05/03/2013 |
| Orphan Designation: | Treatment of symptoms of Grade 2 and Grade 3 late xerostomia from parotid gland hypofunction caused by radiotherapy for cancer of the oral cavity. |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
MeiraGTx, LLC 450 East 29th Street 15th Floor New York, New York 10016 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







